asthma: symbicort and variants for both reliever and maintenance treatment
A recent article confirmed the superiority of prescribing budesonide/formoterol (eg symbicort, and its ilk) as both the maintenance and the rescue inhaler, in a Korean real-world study (see asthma symbicort as maint and rescue best JAlerCLinImmunPractice2022 in dropbox, or doi.org/10.1016/j.jaip.2022.06.009 Brief background: there were 2 pivotal studies (SYGMA1 and SYGMA2) that set in motion a profound change in treating adult asthmatic patients, codified in the quite impressive global GINA recommendations of 2019: http://gmodestmedblogs.blogspot.com/2019/10/new-and-improved-asthma-guidelines.html . see below for more Details : -- retrospective data analysis from the medical records of the Ajou University Medical Center in Korea of adult asthmatics, from 2008 to 2021 -- patients were divided into and propensity score-matched for MART (Maintenance and Reliever Therapy, using inhaled corticosteroid with formoterol) versus non-MART (using ...